These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 18272531)

  • 21. Comment on "Brain IRS2 signaling coordinates life span and nutrient homeostasis".
    Selman C; Lingard S; Gems D; Partridge L; Withers DJ
    Science; 2008 May; 320(5879):1012; author reply 1012. PubMed ID: 18497277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of recent genome-wide association scans in lupus.
    Graham RR; Hom G; Ortmann W; Behrens TW
    J Intern Med; 2009 Jun; 265(6):680-8. PubMed ID: 19493061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic association of interferon-alpha subtypes 1, 2 and 5 in systemic lupus erythematosus.
    Hirankarn N; Tangwattanachuleeporn M; Wongpiyabovorn J; Wongchinsri J; Avihingsanon Y
    Tissue Antigens; 2008 Dec; 72(6):588-92. PubMed ID: 19000144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
    Kumar S; Benseler SM; Kirby-Allen M; Silverman ED
    Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developments in the scientific understanding of lupus.
    Ardoin SP; Pisetsky DS
    Arthritis Res Ther; 2008; 10(5):218. PubMed ID: 18947369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoreactive anti-DNA transgenic B cells in lupus-prone New Zealand black/New Zealand white mice show near perfect L chain allelic exclusion.
    Makdasi E; Fischel R; Kat I; Eilat D
    J Immunol; 2009 May; 182(10):6143-8. PubMed ID: 19414767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B-cell activating factor (BAFF) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupus.
    Parameswaran R; Ben David H; Sharabi A; Zinger H; Mozes E
    Clin Immunol; 2009 May; 131(2):223-32. PubMed ID: 19188092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A functional Ser(413)/Ser(413) PAI-2 polymorphism is associated with susceptibility and damage index score in systemic lupus erythematosus.
    Palafox-Sánchez CA; Vázquez-Del Mercado M; Orozco-Barocio G; García-De la Torre I; Torres-Carrillo N; Torres-Carrillo NM; Illades-Aguiar B; Muñoz-Valle JF
    Clin Appl Thromb Hemost; 2009; 15(2):233-8. PubMed ID: 18818228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of three systemic lupus erythematosus susceptibility factors, PD-1.3A, C4AQ0, and low levels of mannan-binding lectin, with autoimmune manifestations in Icelandic multicase systemic lupus erythematosus families.
    Kristjansdottir H; Saevarsdottir S; Gröndal G; Alarcón-Riquelme ME; Erlendsson K; Valdimarsson H; Steinsson K
    Arthritis Rheum; 2008 Dec; 58(12):3865-72. PubMed ID: 19035512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of ERCC2/XPD functional polymorphisms in systemic lupus erythematosus.
    Wan L; Lin YJ; Sheu JJ; Huang CM; Tsai Y; Tsai CH; Wong W; Tsai FJ
    Int J Immunogenet; 2009 Feb; 36(1):33-7. PubMed ID: 19055600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA methylation in T cells from idiopathic lupus and drug-induced lupus patients.
    Zhou Y; Lu Q
    Autoimmun Rev; 2008 May; 7(5):376-83. PubMed ID: 18486925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tonic B cell activation by Radioprotective105/MD-1 promotes disease progression in MRL/lpr mice.
    Kobayashi T; Takahashi K; Nagai Y; Shibata T; Otani M; Izui S; Akira S; Gotoh Y; Kiyono H; Miyake K
    Int Immunol; 2008 Jul; 20(7):881-91. PubMed ID: 18492657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral B cell abnormalities and disease activity in systemic lupus erythematosus.
    Hostmann A; Jacobi AM; Mei H; Hiepe F; Dörner T
    Lupus; 2008 Dec; 17(12):1064-9. PubMed ID: 19029273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2007 Changsha International Symposium on Lupus.
    Lu QJ; Li YP
    Chin Med J (Engl); 2007 Aug; 120(16):1471-2. PubMed ID: 17825185
    [No Abstract]   [Full Text] [Related]  

  • 35. Three checkpoints in lupus development: central tolerance in adaptive immunity, peripheral amplification by innate immunity and end-organ inflammation.
    Kanta H; Mohan C
    Genes Immun; 2009 Jul; 10(5):390-6. PubMed ID: 19262576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fcgamma receptor-dependent expansion of a hyperactive monocyte subset in lupus-prone mice.
    Santiago-Raber ML; Amano H; Amano E; Baudino L; Otani M; Lin Q; Nimmerjahn F; Verbeek JS; Ravetch JV; Takasaki Y; Hirose S; Izui S
    Arthritis Rheum; 2009 Aug; 60(8):2408-17. PubMed ID: 19644866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNASE I mutation and systemic lupus erythematosus in a Spanish population: comment on the article by Tew et al.
    Balada E; Ordi-Ros J; Hernanz S; Villarreal J; Cortés F; Vilardell-Tarrés M; Labrador M
    Arthritis Rheum; 2002 Jul; 46(7):1974-6; author reply 1976-7. PubMed ID: 12124889
    [No Abstract]   [Full Text] [Related]  

  • 38. Genetic susceptibility to spontaneous lupus in mice.
    Kono DH; Theofilopoulos AN
    Curr Dir Autoimmun; 1999; 1():72-98. PubMed ID: 11791449
    [No Abstract]   [Full Text] [Related]  

  • 39. Avoiding the effect of linked genes is crucial to elucidate the role of Apcs in autoimmunity.
    Tamaoki T; Tezuka H; Okada Y; Ito S; Shimura H; Sakamoto M; Endo T; Ozaki Y; Kanba S; Maeda S
    Nat Med; 2005 Jan; 11(1):11-2; author reply 12-3. PubMed ID: 15635430
    [No Abstract]   [Full Text] [Related]  

  • 40. Epigenetic considerations in investigating the cause of systemic lupus erythematosus: comment on the article by Chagnon et al.
    Brooks WH
    Arthritis Rheum; 2007 Mar; 56(3):1035. PubMed ID: 17330258
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.